PHIO

PHIO PHARMACEUTICALS CORP

PHIO·71880W501·US·Common Stock·Healthcare - Biotechnology-13D/G

PHIO (PHIO PHARMACEUTICALS CORP) is held by 15 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($179,649), JANE STREET GROUP, LLC ($145,410), VANGUARD CAPITAL MANAGEMENT LLC ($97,421). Net institutional sentiment: Bullish.

15
Holders
Avg rating(4 Elite)
$679,226
Total Value
79% (18)
Fund Consensus
11 buying - 3 selling
PHIOSmart Money Verdict
View all
Held by 15 funds
4 elite
Who's Trading
InsiderBJBitterman Robert JBuy $10KJun 26, 2026
ActivistCICVI Investments, Inc.9.9%Feb 17, 2026
ActivistMPMitchell P. Kopin9.1%Feb 13, 2026
InsiderBJBitterman Robert JBuy $5KDec 23, 2025
ActivistOAOrca Capital AG4.9%Dec 11, 2025
InsiderBJBitterman Robert JBuy $6KNov 21, 2025
InsiderBJBitterman Robert JBuy $6KNov 18, 2025
InsiderBJBitterman Robert JBuy $2KMay 22, 2025
InsiderBJBitterman Robert JBuy $5KMay 21, 2025
InsiderFLFerrara Robert LBuy $5KMay 20, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
147,254(+59.0%)$179,6490.0%-16.41%
22
New
119,189$145,4100.0%+0.99%
34
New
79,853$97,4210.0%+0.99%
33
Increased
45,000(+5.9%)$54,9000.0%-26.78%
22
New
38,169$46,5660.0%+0.99%
31
Increased
32,495(+124.2%)$39,6440.0%+0.54%
22
Increased
26,987(+214.0%)$32,9250.0%+0.61%
22
New
24,868$30,3390.0%+0.99%
27
Unchanged
23,758$28,9850.0%0.00%
0
Unchanged
10,000$12,2000.0%0.00%
0
Unchanged
6,000$7,3200.0%-46.06%
0
New
2,000$2,4400.0%+0.99%
19
New
1,025$1,2510.0%+0.99%
17
Unchanged
110$1340.0%-20.93%
0
New
34,732$420.0%+0.99%
15
Exited
0(-100.0%)$21,0960.0%-0.98%
0
Exited
0(-100.0%)$11,0000.0%-0.98%
0
Exited
0(-100.0%)$1,4830.0%-56.45%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used